Bacterial profile and their antimicrobial resistance patterns among patients with community-acquired pneumonia in

Sajad Hassanzadeh1, Seyed Sajjad Khoramrooz2, Farzad Mazloomirad3

  • 1Department of Internal Medicine, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran.

PubMed
Abstract

Insights

This study identified Streptococcus pneumoniae as the most common cause of community-acquired pneumonia (CAP) in Yasuj. Antibiotic resistance was significant, with cefepime showing effectiveness against Gram-negative bacteria in CAP patients.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Community-acquired pneumonia (CAP) is a frequent and potentially life-threatening infection.
  • Understanding the causative pathogens and their antibiotic resistance patterns is crucial for effective treatment.
  • This study focuses on CAP patients in Yasuj, Iran, from 2018 to 2019.

Purpose of the Study:

  • To determine the frequency of pathogenic bacteria in sputum of CAP patients.
  • To analyze the antibiotic resistance patterns of these identified bacteria.
  • To provide data for guiding antimicrobial therapy in the region.

Main Methods:

  • Sputum samples were collected from 128 CAP patients.
  • Bacterial identification was performed using culture media, biochemical tests, and PCR.
  • Antibiotic susceptibility testing was conducted using the disc diffusion method.

Main Results:

  • The most common bacteria identified were Streptococcus pneumoniae (24.1%), Hemophilus influenzae (18%), Staphylococcus aureus (13.5%), and Moraxella catarrhalis (11.4%).
  • High resistance rates were observed in Gram-positive bacteria to clindamycin, ciprofloxacin, and amoxicillin.
  • Gram-negative bacteria showed resistance to levofloxacin, rifampin, and ceftriaxone; cefepime was most effective against them.

Conclusions:

  • Streptococcus pneumoniae is a primary pathogen in CAP in the studied population.
  • The findings highlight significant antimicrobial resistance, necessitating careful antibiotic selection.
  • Cefepime is recommended for treating Gram-negative bacterial CAP infections in this region.